On-Demand CME Videos
Targeting Onychomycosis with Topicals: Treat to Terminate: Online CME Activity
About
This activity was recorded at the Winter Clinical Dermatology Conference-Hawaii on January 17, 2023
CME Seminar in Depth: Targeting Onychomycosis with Topicals: Treat to Terminate
This activity is supported by an educational grant from Ortho Dermatologics.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
March 20, 2023
March 20, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the key data for the management of onychomycosis with a focus on topical treatment options
Identify patients for the management of onychomycosis
Discuss strategies to optimize care for patients with onychomycosis
Intended Audience
Faculty
Boni Elewski, MD
James Elder Professor and Chair of Dermatology
University of Alabama at Birmingham
Birmingham, AL
David Pariser, MD
Professor of Dermatology
Eastern Virginia Medical School
Norfolk, VA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
CONFLICTS OF INTEREST/DISCLOSURES
In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer.
Disclosures are as follows:
Grant/Research Support: Ortho Dermatology
Consultant: Ortho Dermatology
Dr. Pariser has disclosed that he has no relevant financial relationships with any Ineligible company in the past 24 months.
The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.